ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm
SO WHAT: If you purchased Neumora common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Neumora class action, go to https://rosenlegal.com/submit-form/?case_id=34655 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 7, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, the Offering Documents contained false and/or misleading statements and/or failed to disclose that: (1) in order for Neumora to justify conducting its Phase Three Program, Neumora was forced to amend BlackThorn's original Phase Two Trial inclusion criteria to include a patient population with moderate to severe major depressive disorder ('MDD') to show that Navacaprant offered a statistically significant improvement in treating MDD; (2) and to that same end, Neumora also added a prespecified analysis to the Phase Two statistical analysis plan, focusing on patients suffering from moderate to severe MDD; and (3) the Phase Two Trials lacked adequate data, particularly in regards to the patient population size and the ratio of male to female patients within the patient population, to be able to accurately predict the results of the KOASTAL-1 study. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Neumora class action, go to https://rosenlegal.com/submit-form/?case_id=34655 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
20 minutes ago
- Business Wire
Redwood Trust Launches Reopening of $50 Million of 7.75% Convertible Senior Notes Due 2027
MILL VALLEY, Calif.--(BUSINESS WIRE)--Redwood Trust, Inc. (NYSE: RWT; 'Redwood' or the 'Company') today announced that it plans to offer, subject to market and other conditions, $50 million aggregate principal amount of its 7.75% convertible senior notes due 2027 (the 'Notes') in a direct placement registered under the Securities Act of 1933, as amended. The Notes will be issued as a reopening of, and will be part of the same series as, the 7.75% convertible senior notes due 2027 that the Company originally issued in June 2022 (the 'Initial Notes') and the 7.75% convertible senior notes due 2027 that the Company issued in October 2024 (the 'Initial Additional Notes' and, together with the Initial Notes, the 'Existing Notes'). Currently, $247,170,000 aggregate principal amount of Existing Notes are outstanding. Redwood intends to use the net proceeds from this offering for general corporate purposes, which may include (i) funding of Redwood's operating business and investment activity, which may include funding its residential and business purpose lending mortgage banking businesses, acquiring mortgage-backed securities for its investment portfolio, and funding strategic acquisitions and investments and/or (ii) the repayment of existing indebtedness, which may include the repurchase or repayment of a portion of the 5.75% exchangeable senior notes due 2025 issued by one of Redwood's subsidiaries. This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any securities referred to in this press release, nor will there be any sale of any such securities, in any state or other jurisdiction in which such offer, sale or solicitation would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. About Redwood Trust Redwood Trust, Inc. (NYSE: RWT) is a specialty finance company focused on several distinct areas of housing credit where we provide liquidity to growing segments of the U.S. housing market not well served by government programs. We deliver customized housing credit investments to a diverse mix of investors, through our best-in-class securitization platforms, whole-loan distribution activities, joint ventures and our publicly traded shares. We operate through three core residential housing-focused operating platforms — Sequoia, Aspire, and CoreVest — alongside our complementary Redwood Investments portfolio which is primarily composed of assets we source through these platforms. In addition, through RWT Horizons®, our venture investing initiative, we invest in early-stage companies that have a direct nexus to our operating platforms. Our goal is to provide attractive returns to shareholders through a stable and growing stream of earnings and dividends, capital appreciation, and a commitment to technological innovation that facilitates risk-minded scale. Redwood Trust is internally managed and structured as a real estate investment trust ('REIT') for tax purposes. CAUTIONARY STATEMENT: This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, such as statements related to the placement of Notes and the expected use of the net proceeds. Forward-looking statements involve numerous risks and uncertainties. Redwood's actual results may differ materially from those projected, and Redwood cautions investors not to place undue reliance on the forward-looking statements contained in this release. Forward-looking statements are not historical in nature and can be identified by words such as 'anticipate,' 'estimate,' 'will,' 'should,' 'expect,' 'believe,' 'intend,' 'seek,' 'plan,' and similar expressions or their negative forms, or by references to strategy, plans, or intentions. These forward-looking statements are subject to risks and uncertainties, including, among other things, those described in Redwood's filings with the Securities and Exchange Commission. Redwood undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Business Wire
20 minutes ago
- Business Wire
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting from allegations that Telix may have issued materially misleading business information to the investing public. So What: If you purchased Telix securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. What to do next: To join the prospective class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@ for information on the class action. What is this about: On July 22, 2025, Telix disclosed receipt of a subpoena from the U.S. Securities and Exchange Commission, which was 'seeking various documents and information primarily relating to the Company's disclosures regarding the development of the Company's prostate cancer therapeutic candidates.' On this news, Telix's American Depositary Receipt ('ADR') price fell $1.70 per ADR, or 10.44%, to close at $14.58 per ADR on July 23, 2025. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Attorney Advertising. Prior results do not guarantee a similar outcome.
CNBC
22 minutes ago
- CNBC
Household robots are about to get a big price cut — if China's top 'robovac' player has its way
BEIJING — Household robots for cleaning are about to quickly become an affordable reality. At least that's what Quan Gang, president of Beijing-based robot vacuum cleaner company Roborock, has in mind as he strategizes for the next five years. The company ranks first among smart vacuums by global market share, according to IDC Research. Last week, it reported a nearly 79% revenue surge in the first half of this year. About half of sales came from outside China. In an exclusive interview with CNBC on Wednesday, Quan predicted that human-like robots will become part of many households by 2030, thanks largely to advances in generative artificial intelligence. And before then, he expects, Roborock can make its latest, high-end cleaner with an AI-powered robotic arm so cheap that the mass market will be able to buy it — for at most a few hundred U.S. dollars. "If we only focus on the premium segment, in the end, other than being the best robotic vacuum cleaner company in the world, we will have nothing," Quan said in Mandarin, translated by CNBC. He noted that robot vacuums still don't have a very high household penetration rate. China, the largest market for the robot vacuums by value, has a penetration rate of only 5.6%, while the United States, the second-largest market, has a 22% penetration rate, according to Euromonitor estimates for 2025. The firm predicts penetration in the U.S. will tick up to 24.1% over the next two years, and edge down to 5.5% in China. Competition in the robotic vacuum + robotic arm category heated up earlier this year at the U.S. Consumer Electronics Show, with Roborock and at least two other Chinese competitors releasing demos. The AI-powered arm removes obstacles from the cleaner's path as it rolls autonomously around the house. So far, only Roborock has started selling one, called the Saros Z70 — but with a hefty price tag of around $2,600 on The site shows 141 reviews and a 4.6 rating. Roborock did not share specific sales figures. Initial reviews of the Saros Z70 from U.S. tech sites such as Mashable and Wired weren't impressed, especially given the price, but hoped for more capable versions in the near future. Both recommended that consumers stick with the more traditional Roborock Saros 10R — which retails for $1,600. Robot vacuum cleaner companies should develop products that "bridge cutting-edge technologies and mainstream price points to accelerate adoption," said Jin Liu, senior analyst of small appliances at Euromonitor International. But even if the price comes down, it would only be a small step toward having a robot help with cooking and other household chores. Vacuum cleaners are the "only successful application [of robots] in our homes to date," said Jeff Burnstein, president of the Association for Advancing Automation (A3). "This is after four decades of talking about how we're going to have robots in our home." "What made the [robot] vacuum cleaner so successful is it didn't cost that much," he said. For the same thing to happen for humanoids to enter homes, he said, there needs to be a compelling quality for the price. Humanoids, such as those from Chinese startup Unitree, still cost tens of thousands of U.S. dollars and don't have clear household use cases yet. Despite its mass market ambitions, Roborock said that because of tariffs, it had to raise the Saros Z70 price by $700 from the original $1,899. Quan said Roborock started working with suppliers late last year in Vietnam, where he said the company can fulfill all its North American orders. Looking ahead, he said the company is considering global supply chain partnerships, but not necessarily to invest in building its own factories. Roborock's plans for a Hong Kong listing are primarily to raise capital for international expansion, Quan said, noting the company is also expanding beyond vacuums. Despite Roborock's 79% revenue surge, the company more than doubled its spending, largely on research and development, steepening the company's losses in the first half of the year. Quan said the company has hired nearly 100 AI experts this year and is still hiring — with an eye to add a total of nearly 200 AI experts this year. He said many of the new hires have overseas education or work experience. The company built a dedicated AI lab in Shanghai and a research institute in Shenzhen, soon after Roborock's founding in 2014. When asked about computing power, Quan said there are many solutions and that buying Nvidia chips aren't the only option. As for improving the AI-powered robotic arm and making it cheaper, "the challenge lies primarily with the algorithm and data," he said, not the hardware. As AI becomes more critical for household robots, Quan has an even bigger vision. "If this robot in your home needs to clean, then it will have to integrate the cleaning knowledge that Roborock has accumulated over the years in algorithms, models, data and training," he said. "Then it can be installed onto the robot like an app." "This robot may be Tesla's, or Unitree's, or someone else's, ... but in the area of cleaning, it will be inseparable from Roborock," he said, claiming the company has the best data on cleaning tasks. Another company might have the best data for robots to cook, he said. The humanoid market will likely reach $5 trillion by 2050, with $800 billion in China alone, according to Morgan Stanley estimates. "With humanoids, if they can't do more than one thing, then they're competing against an existing form factor that can do one thing very well," Burnstein said. But ne noted companies around the world expect there's a big market for safe, affordable humanoids that can cook, clean, help the elderly and do other things. "We're not there yet with the technology, but maybe we'll get there and maybe that multitasking would be the differentiator potentially," he said. "So you wouldn't need 5 robots. You might just need one."
